Browsing Tag
US FDA approval
2 posts
Can Glenmark Pharmaceuticals’ tentative FDA nod for Regadenoson Injection boost its US generics momentum?
Glenmark Pharmaceuticals secures FDA tentative approval for Regadenoson Injection, targeting a USD 660M U.S. cardiac stress agent market.
Lupin launches generic Fenofibrate Capsules in US to target cholesterol management market
Lupin launches generic Fenofibrate Capsules in the U.S., expanding its cardiovascular portfolio and targeting the cholesterol management market.